TDM for mycophenolic acid at no extra cost.
van Gelder
Teun
T
Department of Internal Medicine and Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands. t.vangelder@erasmusmc.nl
D000903:Antibiotics, Antineoplastic / Q000097:blood / Q000493:pharmacokinetics; D003362:Cost-Benefit Analysis; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D016903:Drug Monitoring / Q000379:methods*; D004358:Drug Therapy / Q000191:economics / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000097:blood* / Q000493:pharmacokinetics; D016377:Organ Transplantation / Q000379:methods*; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid